Chorea secondary to striatal encephalitis due to anti-CV2/CRMP5 antibodies. Case description and review of the literature.

نویسندگان

  • J A Crespo-Burillo
  • N Hernando-Quintana
  • P Ruiz-Palomino
  • J Martín-Martínez
چکیده

1. Chunj SJ, Kim JS, Kim JC, Lee SK, Kwon SU, Lee MC, et al. Intracranial dural arteriovenous fistulas: analysis of 60 patients. Cerebrovasc Dis. 2002;13:79—88. 2. Lee PH, Lee JS, Shin DH, Kim BM, Huh K. Parkinsonism as an initial manifestation of dural arteriovenous fistula. Eur J Neurol. 2005;12:403—6. 3. Netravathi M, Pal PK, Bharath RD, Ravishankar S. Intracranial dural arteriovenous fistula presenting as parkinsonism and cognitive dysfunction. J Clin Neurosci. 2011;18:138—40. 4. Cognard C, Gobin YP, Pierot L, Bailly AL, houdart E, Merland JJ, et al. Cerebral dural arteriovenous fistulas: clinical and angiographic correlation with a revised classification of venous drainage. Radiology. 1995;194:671—80. 5. Nogueira RG, Baccin CE, Rabinov JD, Pryor JC, Buonanno FS, Hirsch JA. Reversible parkinsonism after treatment of dural arteriovenous fistula. J Clin Neurosci. 2009;16:341—3. 6. Matsuda S, Waragai M, Shinotoh H, Takahashi N, Takagi K, Hattori T. Intracranial dural arteriovenous fistula (DAVF) presenting progressive dementia and parkinsonism. J Neurol Sci. 1999;165:43—7. 7. Kwon BJ, Han MH, Kang HS, Chang KH. MR Imaging findings of intracranial dural arteriovenous fistulas: Relations with venous drainage patterns. Am J Neuroradiol. 2005;26:2500—7. 8. Willinsky R, Goyal M, TerBrugge K, Montanera W. Tortuous, engorged pial veins in intracranial dural arteriovenous fistulas: correlations with presentation, location, and MR findings in 122 patients. Am J Neuroradiol. 1999;20:1031—6. 9. Zeidman SM, Monsein LH, Arosarena O, Aletich V, Biafore JM, Dawson RC, et al. Reversibility of white matter changes and dementia after treatment of dural fistulas. Am J Neuroradiol. 1995;16:1080—3. 10. Geibprasert S, Pongpech S, Jiarakongmun P, Shroff M, Armstrong D, Krings T. Radiologic assessment of brain arteriovenous malformations: What clinicians needs to know. Radiographics. 2010;30:483—501.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 antibodies.

OBJECTIVE Anti-Hu antibodies (Hu-Ab) and anti-CV2/CRMP5 antibodies (CV2/CRMP5-Ab) have been identified in association with paraneoplastic neurological disorders. However, it is not clear whether these antibodies are associated with specific neurological symptoms or are only markers of anti-cancer immune reaction. METHODS To address this question, 37 patients with CV2/CRMP5-Ab and 324 patients...

متن کامل

Paraneoplastic Choreoathetosis in a Patient with Small Cell Lung Carcinoma and Anti-CRMP5/CV2: A Case Report

INTRODUCTION The occurrence of more or less monosymptomatic paraneoplastic choreoathetosis associated with anti-CRMP5/CV2 antibodies is rare. Typically, such autoantibodies are associated with a more classical syndrome - paraneoplastic encephalomyelitis. Frequently, small cell lung carcinoma (SCLC) is the related neoplastic finding. CASE REPORT We present a 71-year-old woman who developed vis...

متن کامل

Autoimmune encephalitis: An emerging entity

The importance of immunology in relation to neurological diseases has long been recognized. The first description of immune mediated encephalitis was in 1960’s by Corsellis et al 1 and Brierley et al 2 , who separately documented a form of encephalitis with poor prognosis in adults with tumours. The demonstration of anti-neuronal antibodies associated with this form of encephalitis (Hu, CV2/CRM...

متن کامل

Severe parkinsonism associated with anti-CRMP5 antibody-positive paraneoplastic neurological syndrome and abnormal signal intensity in the bilateral basal ganglia

INTRODUCTION Anticollapsin response mediator protein 5 antibody (anti-CRMP5 antibody, also known as anti-CV2 antibody) is usually associated with small-cell lung carcinoma (SCLC) or thymoma. Although optic neuropathy, cerebellar ataxia and chorea are considered typical clinical features of paraneoplastic neurological syndrome (PNS) associated with anti-CRMP5 antibody, the neurological involveme...

متن کامل

Paraneoplastic chorea caused by anti-CRMP5 antibodies associated with small cell lung cancer.

The appearance of subacute choreic symptoms often poses a diagnostic challenge. Many entities cause these symptoms, and they may be hereditary or secondary to drugs, toxic metabolic disorders, or structural lesions (vascular, oncological, or inflammatory). It is also possible, albeit extremely rare, for symptoms to be caused by a paraneoplastic syndrome. This would generally be associated with ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:
  • Neurologia

دوره 30 7  شماره 

صفحات  -

تاریخ انتشار 2015